Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2003
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087401 Quaternary ammonium or phosphonium phase transfer catalyst
05/08/2003CA2465682A1 Methods of treating leukemia
05/08/2003CA2465382A1 Indole compound and medicinal use thereof
05/08/2003CA2465350A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003CA2465344A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003CA2464342A1 Therapeutic isoquinoline compounds
05/08/2003CA2463822A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
05/08/2003CA2463821A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003CA2463441A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/07/2003EP1308445A1 5-heteroatom-substituted pyrazoles
05/07/2003EP1308441A1 2-aminopyridine compounds and use thereof as drugs
05/07/2003EP1308158A1 Sulfonylaryl- and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307445A1 Benzofuran derivatives and their use as antibacterial agents
05/07/2003EP1307441A1 1,3-dioxolanes with antitussive activity
05/07/2003EP1307440A1 2,2-disubstituted 1,3-dioxolanes as antitussive agents
05/07/2003EP1307237A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
05/07/2003EP1307204A1 Protease inhibitors
05/07/2003EP1307203A1 Protease inhibitors
05/07/2003EP1214316B1 Five membered-ring compounds and utilization thereof in liquid crystal mixtures
05/07/2003EP1204658B1 Benzofurylpiperazine serotonin agonists
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1054863B1 2-aminoquinoline derivatives having d4-agonistic activity
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0885190B1 N-substituted 4-((4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties
05/07/2003EP0869791B1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
05/07/2003EP0814807B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/07/2003EP0806416B1 Huperzine a derivatives, their preparation and their use
05/07/2003EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0719272B1 Pyrimidine derivatives for labeled binding partners
05/07/2003CN1416346A Peotease inhibitors
05/07/2003CN1416344A Novel wse of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-chromane and its physiologically acceptable salts
05/07/2003CN1107673C Pesticidal 1-aryl-3-iminopyrazoles
05/07/2003CN1107672C Intermediate for preparing pyrazole derivatives
05/06/2003US6559323 Degradation of hydrazone compound to diazo compound; catalysis with transition metal; reaction with sulfide
05/06/2003US6559310 Aryl borates
05/06/2003US6559173 organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
05/06/2003US6559172 Treatment of bacterial infections, particularly through the inhibition of FAB I. and antiobiotics
05/06/2003US6559169 For therapy of depression, anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder attention deficit disorder,obsessive compulsive disorder, obesity, eating disorders, sexual dysfunction
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559153 1-(4-(((4-Amino-6,7-dimethoxy-quinazolin-2-yl)-methyl-amino) methyl)-4-phenyl-piperidin-1-yl)-1-cyclopropyl-methanone; treating disease states ameliorated by blockade of alpha-1 adrenoceptors; sleep/psychological disorders
05/06/2003US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example
05/06/2003US6559145 Heterocycle carboxamides as antiviral agents
05/06/2003US6559144 Integrin inhibitors used to treat circulatory disorders, for thrombosis, myocardial infarct, coronary heart disease, arteriosclerosis, osteoporosis, pathological processes maintained or propagated by angiogenesis and tumor therapy
05/06/2003US6559137 Characterized by favorable aqueous solubility, high oral bioavailability and facile in vivo generation of the active ingredient
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306373A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/02/2003EP1306371A1 Cyclic imines
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1305309A1 Lactam inhibitors of factor xa which are useful for the treatment of thrombosis
05/02/2003EP1305308A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
05/02/2003EP1305307A1 Indole derivatives useful for the treatment of cns disorders
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305028A2 Antimicrobial biaryl compounds
05/02/2003EP1305026A2 Barbituric acid analogs as therapeutic agents
05/02/2003EP1214315B1 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
05/02/2003EP1200404B1 Process for the preparation of spiro[(4-cyclohexanone)- [3h] indol-2'[1'h]-one derivatives
05/02/2003EP1105381B1 Dibenzothiophene compounds and methods of use thereof
05/02/2003EP1100796B1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
05/02/2003EP1070058B1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides
05/02/2003EP1045846B1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
05/02/2003EP1037886B1 Triazine angiogenesis inhibitors
05/02/2003EP1034166B1 Substituted 2-phenyl-3(2h)-pyridazinones
05/02/2003EP0988035B1 Caspases and apoptosis
05/02/2003EP0901482B1 Benzofuran carboxamides and their therapeutic use
05/02/2003EP0811006B1 Benzopyran-containing compounds and method for their use
05/02/2003EP0772593B1 Thiopyridyl compounds for controlling helicobacter bacteria
05/02/2003EP0724387B1 Angiotension ii receptor antagonists for the treatment of chronic anti-inflammatory diseases
05/02/2003CA2411011A1 5-heteroatom-substituted pyrazoles
05/02/2003CA2410466A1 Hydrazinyl and nitrogen oxide pyrazoles
05/01/2003WO2003035647A1 Alkyl ether derivatives or salts thereof
05/01/2003WO2003035645A1 Novel 4-(2-furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035643A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/01/2003WO2003035639A1 Pyrimidine compound and medicinal composition thereof
05/01/2003WO2003035638A1 4-imidazolin-2-one compounds
05/01/2003WO2003035627A1 Piperazine derivatives with ccr1 receptor antagonist activity
05/01/2003WO2003035626A2 Azole derivatives and pharmaceutical compositions containing them
05/01/2003WO2003035625A1 Substituted indazole compounds for the treatment of inflammation
05/01/2003WO2003035624A1 Quinoline compound
05/01/2003WO2003035620A1 Bicyclic compound
05/01/2003WO2003035617A2 Derivatives of uk-2a
05/01/2003WO2003035615A2 Tyrosine kinase inhibitors
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003035064A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
05/01/2003WO2003035057A1 Inhibitors of dipeptidyl peptidase iv
05/01/2003WO2002102782A3 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE
05/01/2003WO2002090352A3 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
05/01/2003WO2002079186A3 Aminopiperidine derivatives as modulators of chemokine receptor activity
05/01/2003WO2002076438A3 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
05/01/2003WO2002048717A3 Acid-labile isotope-coded extractant (alice) in mass spectrometric analysis
05/01/2003WO2002038553A3 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/01/2003US20030083501 Process for preparing paroxetine HCl which limits formation of pink colored compounds
05/01/2003US20030083365 Such as 1-(3-(((3,4-dihydro-2H-1-benzopyran-2-yl)methyl) amino)-propyl)tetrahydro-2(1H)-pyrimidinone for treatment of irritable bowel syndrome and other gastrointestinal disorders
05/01/2003US20030083362 Synthesis and antimicrobial activity of novel dicationic"reversed amidines"
05/01/2003US20030083361 Naphtho(1,2-d)imidazole derivatives; treating thrombocytopenia
1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 694